The Priority Review program is a new initiative launched by the current administration. It was first announced in June of ...

A gene therapy from Regeneron, a pancreatic cancer medicine from Revolution Medicines and a porphyria drug from Disc Medicine ...

Dr. Marty Makary, FDA Commissioner, discusses the reforms the FDA is making towards reducing the price of IVF medications. He ...

The FDA in June launched the new Commissioner's National Priority Voucher pilot program under which it could issue vouchers ...

The Pakistan People's Party (PPP) has given the government one month to fulfill its promises.

Iowa Republican U.S. Rep. Ashley Hinson on Friday criticized the White House for a thread on Twitter that’s gone viral highlighting Republican lawmakers for criticizing student loan forgiveness after ...

The FDA named the first nine products to undergo a new expedited review process that takes 1 to 2 months, the agency announced on Thursday.

Shares of Revolution Medicines gained after the Food and Drug Administration granted a priority voucher to speed up the development and review of the company's cancer treatment. The stock rose 8.9% to ...

FDA announced the first nine recipients of priority review vouchers, which offers expedited drug review to products aligned ...

The FDA has named the first nine medications selected for its national priority review voucher program, which aims to shorten drug review timelines to ...

Shares of Disc Medicine jumped after the company said it received a Commissioner's National Priority Voucher from the Food and Drug Administration for its drug bitopertin. The stock climbed 27% to $94 ...

WASHINGTON (AP) — The Food and Drug Administration on Thursday announced the first round of experimental drugs that will ...